946077-32-3Relevant articles and documents
New (3-(1: H -benzo [d] imidazol-2-yl))/(3-(3 H -imidazo[4,5- b] pyridin-2-yl))-(1 H -indol-5-yl)(3,4,5-trimethoxyphenyl)methanone conjugates as tubulin polymerization inhibitors
Mullagiri, Kishore,Nayak, V. Lakshma,Sunkari, Satish,Mani, Geeta Sai,Guggilapu, Sravanthi Devi,Nagaraju, Burri,Alarifi, Abdullah,Kamal, Ahmed
, p. 275 - 281 (2018)
A series of new (3-(1H-benzo[d]imidazol-2-yl))/(3-(3H-imidazo[4,5-b]pyridin-2-yl))-(1H-indol-5-yl)(3,4,5-trimethoxyphenyl)methanone conjugates 4-6(a-i) were synthesized and evaluated for their antiproliferative activity on selected human cancer cell lines
Novel potent antimitotic heterocyclic ketones: Synthesis, antiproliferative activity, and structure-activity relationships
Hu, Laixing,Jiang, Jian-dong,Qu, Jinrong,Li, Yan,Jin, Jie,Li, Zhuo-rong,Boykin, David W.
, p. 3613 - 3617 (2008/02/05)
We report the synthesis, antiproliferative activity, and SAR of novel heterocyclic ketones derived from carbazole sulfonamides. Most of the heterocyclic ketones showed strong cytotoxicities. (N-1-Methylindole-5-yl)-(3,4,5-trimethoxyphenyl)-methanone 8b gave the most potent cytotoxicity (9.2-26 nM) against seven human tumor cell lines. The mechanism of action of the heterocyclic ketones appears to involve targeting of tubulin, similar to that of CA-4 and different from the carbazole sulfonamides.